129 related articles for article (PubMed ID: 15687710)
1. DNA vaccines suppress angiogenesis and protect against growth of breast cancer metastases.
Mizutani N; Luo Y; Mizutani M; Reisfeld RA; Xiang R
Breast Dis; 2004; 20():81-91. PubMed ID: 15687710
[TBL] [Abstract][Full Text] [Related]
2. DNA vaccines suppress tumor growth and metastases by the induction of anti-angiogenesis.
Reisfeld RA; Niethammer AG; Luo Y; Xiang R
Immunol Rev; 2004 Jun; 199():181-90. PubMed ID: 15233734
[TBL] [Abstract][Full Text] [Related]
3. DNA vaccines designed to inhibit tumor growth by suppression of angiogenesis.
Reisfeld RA; Niethammer AG; Luo Y; Xiang R
Int Arch Allergy Immunol; 2004 Mar; 133(3):295-304. PubMed ID: 14988601
[TBL] [Abstract][Full Text] [Related]
4. Oral DNA vaccines target the tumor vasculature and microenvironment and suppress tumor growth and metastasis.
Xiang R; Luo Y; Niethammer AG; Reisfeld RA
Immunol Rev; 2008 Apr; 222():117-28. PubMed ID: 18363997
[TBL] [Abstract][Full Text] [Related]
5. Targeting tumor vasculature with novel Listeria-based vaccines directed against CD105.
Wood LM; Pan ZK; Guirnalda P; Tsai P; Seavey M; Paterson Y
Cancer Immunol Immunother; 2011 Jul; 60(7):931-42. PubMed ID: 21431419
[TBL] [Abstract][Full Text] [Related]
6. Endoglin (CD105) is a target for an oral DNA vaccine against breast cancer.
Lee SH; Mizutani N; Mizutani M; Luo Y; Zhou H; Kaplan C; Kim SW; Xiang R; Reisfeld RA
Cancer Immunol Immunother; 2006 Dec; 55(12):1565-74. PubMed ID: 16565828
[TBL] [Abstract][Full Text] [Related]
7. A Legumain-based minigene vaccine targets the tumor stroma and suppresses breast cancer growth and angiogenesis.
Lewēn S; Zhou H; Hu HD; Cheng T; Markowitz D; Reisfeld RA; Xiang R; Luo Y
Cancer Immunol Immunother; 2008 Apr; 57(4):507-15. PubMed ID: 17786443
[TBL] [Abstract][Full Text] [Related]
8. Therapeutic antitumor potential of endoglin-based DNA vaccine combined with immunomodulatory agents.
Jarosz M; Jazowiecka-Rakus J; Cichoń T; Głowala-Kosińska M; Smolarczyk R; Smagur A; Malina S; Sochanik A; Szala S
Gene Ther; 2013 Mar; 20(3):262-73. PubMed ID: 22495576
[TBL] [Abstract][Full Text] [Related]
9. FLK-1-based minigene vaccines induce T cell-mediated suppression of angiogenesis and tumor protective immunity in syngeneic BALB/c mice.
Luo Y; Markowitz D; Xiang R; Zhou H; Reisfeld RA
Vaccine; 2007 Feb; 25(8):1409-15. PubMed ID: 17113202
[TBL] [Abstract][Full Text] [Related]
10. [Anti-HER2 vaccines: The HER2 immunotargeting future?].
Ladjemi MZ; Jacot W; Pèlegrin A; Navarro-Teulon I
Pathol Biol (Paris); 2011 Jun; 59(3):173-82. PubMed ID: 19481373
[TBL] [Abstract][Full Text] [Related]
11. Transcription factor Fos-related antigen 1 is an effective target for a breast cancer vaccine.
Luo Y; Zhou H; Mizutani M; Mizutani N; Reisfeld RA; Xiang R
Proc Natl Acad Sci U S A; 2003 Jul; 100(15):8850-5. PubMed ID: 12857959
[TBL] [Abstract][Full Text] [Related]
12. Bacterial surface display of endoglin by antigen 43 induces antitumor effectiveness via bypassing immunotolerance and inhibition of angiogenesis.
Huang FY; Li L; Liu Q; Li YN; Bai RZ; Huang YH; Zhao HG; Guo JL; Zhou SL; Wang H; Lin YY; Tan GH
Int J Cancer; 2014 Apr; 134(8):1981-90. PubMed ID: 24150860
[TBL] [Abstract][Full Text] [Related]
13. Phage-Based Anti-HER2 Vaccination Can Circumvent Immune Tolerance against Breast Cancer.
Bartolacci C; Andreani C; Curcio C; Occhipinti S; Massaccesi L; Giovarelli M; Galeazzi R; Iezzi M; Tilio M; Gambini V; Wang J; Marchini C; Amici A
Cancer Immunol Res; 2018 Dec; 6(12):1486-1498. PubMed ID: 30327365
[TBL] [Abstract][Full Text] [Related]
14. Orally administered DNA vaccine delivery by attenuated Salmonella typhimurium targeting fetal liver kinase 1 inhibits murine Lewis lung carcinoma growth and metastasis.
Zuo SG; Chen Y; Wu ZP; Liu X; Liu C; Zhou YC; Wu CL; Jin CG; Gu YL; Li J; Chen XQ; Li Y; Wei HP; Li LH; Wang XC
Biol Pharm Bull; 2010; 33(2):174-82. PubMed ID: 20118536
[TBL] [Abstract][Full Text] [Related]
15. Immunity against tumor angiogenesis induced by a fusion vaccine with murine beta-defensin 2 and mFlk-1.
Wang YS; Wang GQ; Wen YJ; Wang L; Chen XC; Chen P; Kan B; Li J; Huang C; Lu Y; Zhou Q; Xu N; Li D; Fan LY; Yi T; Wu HB; Wei YQ
Clin Cancer Res; 2007 Nov; 13(22 Pt 1):6779-87. PubMed ID: 18006780
[TBL] [Abstract][Full Text] [Related]
16. [A DNA vaccine encoding the extracellular domain of porcine endoglin induces antitumor immunity in a mouse colon carcinoma model].
Jiao JG; Zhang YD; Li YN
Ai Zheng; 2005 Oct; 24(10):1179-83. PubMed ID: 16219129
[TBL] [Abstract][Full Text] [Related]
17. Combined immunotherapy of breast cancer with EGF and VEGF vaccines from DNA shuffling in a mouse model.
Jin D; Yu X; Chen B; Li Z; Ding J; Zhao X; Qi G
Immunotherapy; 2017 Jun; 9(7):537-553. PubMed ID: 28509606
[TBL] [Abstract][Full Text] [Related]
18. From breast cancer immunobiology to her-2 DNA vaccine and autoimmune sequelae.
Miller F; Jones RF; Jacob J; Kong YC; Wei WZ
Breast Dis; 2004; 20():43-51. PubMed ID: 15687706
[TBL] [Abstract][Full Text] [Related]
19. Antitumor and anti-angiogenesis immunity induced by CR-SEREX-identified Xenopus RHAMM.
Yang HS; Zhang DM; Deng HX; Peng F; Wei YQ
Cancer Sci; 2010 Apr; 101(4):862-8. PubMed ID: 20704574
[TBL] [Abstract][Full Text] [Related]
20. Prevention of metastases with a Mage-b DNA vaccine in a mouse breast tumor model: potential for breast cancer therapy.
Sypniewska RK; Hoflack L; Tarango M; Gauntt S; Leal BZ; Reddick RL; Gravekamp C
Breast Cancer Res Treat; 2005 May; 91(1):19-28. PubMed ID: 15868428
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]